SLC12A3 and Gerstmann syndrome: Her both parents and her son did not develop GS-related symptoms, while the elder brother suffered from mild hypokalemia (3.26 ~ 3.45 mmol/L) and fatigue that were relieved after receiving oral potassium chloride sustained release tablets, which may support the previous findings of intermediate phenotypes in SLC12A3 pathogenic heterozygotes.